RxSight, Inc.

NASDAQ:RXST

33.66 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 45.40834.88729.51228.5830.66720.8117.48916.08812.61511.368.9428.4275.7864.8973.4844.9144.172.7062.888
Cost of Revenue 20.18810.6378.82710.92616.9368.7957.1238.6667.2596.5725.1815.5584.4455.7092.3653.5343.453.182.81
Gross Profit 25.2224.2520.68517.65413.73112.01510.3667.4225.3564.7883.7612.8691.341-0.8121.1191.380.72-0.4740.078
Gross Profit Ratio 0.5550.6950.7010.6180.4480.5770.5930.4610.4250.4210.4210.340.232-0.1660.3210.2810.173-0.1750.027
Reseach & Development Expenses 8.8388.2918.0317.3417.1017.4017.2086.6816.3886.1926.7195.9165.3776.5636.6435.2725.8015.0845.777
General & Administrative Expenses 0000000000000000000
Selling & Marketing Expenses 0000000000000000000
SG&A 25.60824.29223.32421.16519.14218.23916.25515.73114.92614.38813.6211.6199.0766.5025.6114.4033.8253.2493.698
Other Expenses 0-0.02300000000000000000
Operating Expenses 34.44632.58331.35528.50626.24325.6423.46322.41221.31420.5820.33917.53514.45313.06512.2549.6759.6268.3339.475
Operating Income -9.226-8.333-10.67-10.852-12.512-13.625-13.097-14.99-15.958-15.792-16.578-14.666-13.112-13.877-11.135-8.302-8.906-8.807-9.397
Operating Income Ratio -0.203-0.239-0.362-0.38-0.408-0.655-0.749-0.932-1.265-1.39-1.854-1.74-2.266-2.834-3.196-1.689-2.136-3.255-3.254
Total Other Income Expenses Net 2.9012.271.5791.6570.109-0.153-0.115-0.615-0.86-0.94-1.014-1.0690.4350.4034.33734.60139.578-4.035-7.1
Income Before Tax -6.325-6.063-9.091-9.195-12.403-13.778-13.212-15.605-16.818-16.732-17.592-15.734-12.677-13.474-6.79826.29930.672-12.842-16.497
Income Before Tax Ratio -0.139-0.174-0.308-0.322-0.404-0.662-0.755-0.97-1.333-1.473-1.967-1.867-2.191-2.751-1.9515.3527.355-4.746-5.712
Income Tax Expense 0.0130.0160.009-0.0180.0120.0261.6220.0050.4390.1960.0040.002-0.0040.0030.0070.0040.0080.040.005
Net Income -6.338-6.079-9.1-9.177-12.415-13.804-14.834-15.61-16.818-16.732-17.596-15.734-12.673-13.477-6.80526.29530.664-12.882-16.502
Net Income Ratio -0.14-0.174-0.308-0.321-0.405-0.663-0.848-0.97-1.333-1.473-1.968-1.867-2.19-2.752-1.9535.3517.353-4.761-5.714
EPS -0.16-0.16-0.25-0.26-0.35-0.4-0.47-0.56-0.61-0.61-0.64-0.58-0.68-0.51-0.361.380.31-0.68-0.87
EPS Diluted -0.16-0.16-0.25-0.26-0.35-0.4-0.47-0.56-0.61-0.61-0.64-0.58-0.68-0.51-0.361.380.31-0.68-0.87
EBITDA -9.226-5.237-7.945-8.107-11.043-11.18-10.706-13.193-14.539-14.55-15.497-13.636-12.091-11.655-5.134-7.279-7.764-11.853-15.539
EBITDA Ratio -0.203-0.215-0.269-0.342-0.408-0.52-0.669-0.88-1.153-1.281-1.733-1.739-2.09-2.628-2.914-1.481-1.862-2.836-2.816